Second Alzheimer's drug in pipeline can slow the disease by a few months but with safety risk

Another experimental Alzheimer’s drug can modestly slow patients’ inevitable worsening — by about four to seven months, researchers reported Monday.

Eli Lilly and Co. is seeking Food and…